Skip to main content
TipRanks
Go Ultimate75% OFF

Senti Biosciences (SNTI) Ratios

270 Followers

Senti Biosciences Ratios

SNTI's free cash flow for Q2 2026 was $-14.25M. For the 2026 fiscal year, SNTI's free cash flow was increased by $0.00 and operating cash flow was $-14.25M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.674.495.625.684.04
Quick Ratio1.674.495.625.684.04
Cash Ratio1.183.672.843.193.85
Solvency Ratio-1.27-0.65-1.25-1.01-1.44
Operating Cash Flow Ratio-3.11-3.15-4.13-1.93-2.38
Short-Term Operating Cash Flow Coverage0.000.000.000.00-19.87
Net Current Asset Value$ -22.36M$ -13.23M$ 18.63M$ 49.05M$ 22.42M
Leverage Ratios
Debt-to-Assets Ratio0.560.340.320.210.24
Debt-to-Equity Ratio5.171.310.560.290.38
Debt-to-Capital Ratio0.840.570.360.230.27
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio9.163.811.791.421.60
Debt Service Coverage Ratio0.000.000.000.00-21.48
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.137.328.498.445.21
Net Debt to EBITDA-0.220.27-0.030.350.89
Profitability Margins
Gross Profit Margin-16431.82%0.00%100.00%100.00%100.00%
EBIT Margin-279263.64%0.00%-3375.38%-1889.35%-1765.43%
EBITDA Margin-262731.82%0.00%-3100.91%-1770.05%-1634.05%
Operating Profit Margin-289668.18%0.00%-4687.92%-1889.35%-1765.43%
Pretax Profit Margin-279263.64%0.00%-4216.68%-1511.41%-2414.62%
Net Profit Margin-279263.64%0.00%-3592.42%-1771.45%-2414.62%
Continuous Operations Profit Margin-279263.64%0.00%-4216.68%-1511.41%-2414.62%
Net Income Per EBT100.00%100.00%85.20%117.21%100.00%
EBT Per EBIT96.41%86.49%89.95%80.00%136.77%
Return on Assets (ROA)-119.94%-53.95%-59.47%-32.20%-57.21%
Return on Equity (ROE)-1099.27%-205.82%-106.19%-45.74%-91.62%
Return on Capital Employed (ROCE)-171.08%-72.07%-86.81%-38.15%-49.23%
Return on Invested Capital (ROIC)-149.67%-68.24%-83.58%-37.69%-48.21%
Return on Tangible Assets-119.94%-53.95%-59.47%-32.20%-57.21%
Earnings Yield-26.27%-327.24%-242.64%-93.94%-12.85%
Efficiency Ratios
Receivables Turnover0.010.000.115.254.74
Payables Turnover1.240.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.050.040.07
Asset Turnover0.000.000.020.020.02
Working Capital Turnover Ratio0.000.000.030.050.06
Cash Conversion Cycle26167.150.003266.9269.5376.95
Days of Sales Outstanding26462.500.003266.9269.5376.95
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding295.350.000.000.000.00
Operating Cycle26462.500.003266.9269.5376.95
Cash Flow Ratios
Operating Cash Flow Per Share-0.19-9.01-11.81-7.94-7.93
Free Cash Flow Per Share-0.19-9.01-14.52-17.35-9.20
Dividend Paid and CapEx Coverage Ratio-221.65-1592.19-4.35-0.84-6.25
Capital Expenditure Coverage Ratio-221.65-1592.19-4.35-0.84-6.25
Operating Cash Flow Coverage Ratio-1.50-1.23-1.39-0.94-1.52
Operating Cash Flow to Sales Ratio-1974.730.00-26.49-10.62-15.12
Free Cash Flow Yield-18.66%-256.78%-220.02%-123.08%-9.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.38-0.31-0.41-1.06-7.78
Price-to-Sales (P/S) Ratio10628.510.0014.8118.86187.89
Price-to-Book (P/B) Ratio41.840.630.440.497.13
Price-to-Free Cash Flow (P/FCF) Ratio-5.36-0.39-0.45-0.81-10.71
Price-to-Operating Cash Flow Ratio-5.38-0.39-0.56-1.78-12.43
Price-to-Earnings Growth (PEG) Ratio0.000.01-0.01-0.23-0.04
Enterprise Value Multiple-4.26-0.03-0.51-0.71-10.61
Enterprise Value246.30M1.50M31.03M41.44M397.16M
EV to EBITDA-4.26-0.03-0.51-0.71-10.61
EV to Sales11195.380.0015.6912.61173.35
EV to Free Cash Flow-5.64-0.04-0.48-0.54-9.88
EV to Operating Cash Flow-5.67-0.04-0.59-1.19-11.47
Tangible Book Value Per Share0.025.5815.0828.9613.83
Shareholders’ Equity Per Share0.025.5815.0828.9613.83
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.450.750.52
Net Income Per Share-0.27-11.49-16.01-13.25-12.67
Tax Burden1.001.000.851.171.00
Interest Burden1.000.871.250.801.37
Research & Development to Revenue1708.450.0016.258.579.58
SG&A to Revenue1189.230.0017.6311.459.28
Stock-Based Compensation to Revenue259.360.004.894.991.00
Income Quality0.710.780.740.600.63

Currency in USD